Price Transparency—Promise and Peril
Bibliographic Data
| ID | 15808181 |
|---|---|
| Authors | Sherry Glied (0000-0001-9432-1662, New York University, corresponding author) |
| Year | 2021 |
| Volume | 2 |
| Issue | 3 |
| Pages | e210316-e210316 |
| Publication date | 2021-03-04 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | JAMA Health Forum (JOURNAL) |
| Journal identifiers | ISSN: 2689-0186 • E-ISSN: 2689-0186 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/jamahealthforum.2021.0316 |
| PMID | 36218444 |
| OpenAlex | W4249523312 |
| Language | EN |
| Citations received | 2 |
Amid the turmoil of its waning days, 2 Trump administration regulations advancing the goal of price transparency in health care moved forward.On October 26, 2020, the US Department of Labor and the US Department of Health and Human Services finalized a rule mandating insurer price transparency.On December 29, 2020, the District of Columbia Court of Appeals upheld the administration's hospital price transparency rule.The rules both stem from provisions of the Affordable Care Act (ACA) and operate quite similarly.Both require the disclosure of consumer-relevant information in a form intended to make shopping easier and provide information about negotiated rates between clinicians and insurers in a machine-readable file (intended to power apps and research efforts).Given the origins of these rules in the ACA and the near-universal support for the notion of transparency, it is likely that these rules will be maintained by the Biden administration.Although they are unlikely to make much direct difference to US health care costs, these rules are important because they mark the first step along a new path for US health policy
Computer security · Economics · Transparency (behavior · Computer Science · Merger and Competition Analysis
| Citations per year | 0.5 |
|---|---|
| Citation span | 2022 - 2022 (1) |
| Highly cited | No |